how do i switch from semaglutide to tirzepatide Switching dosage chart Is It Safe to Switch

Discover how GLP-1 medications impact gut motility, visceral pain, and different IBS subtypes

Retatrutide is an investigational peptide studied for its interaction with GLP-1, GIP, and glucagon receptors at the cellular level

Curious if compounded semaglutide can help YOU drop those unwanted pounds

Cellular Energy & Stress*

Not most

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.Weekly semaglutide 2.4 mg (Wegovy, Novo Nordisk), a GLP-1 receptor agonist, is the first-approved drug for chronic weight management in adults with general obesity or overweight since 2014.